When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVCR - Investors Take Note: This Biotech Stock Has Multiple Readouts in 2021
NovoCure Limited
Cancer has typically been treated by either radiation, surgery, drugs. But Novocure (NASDAQ: NVCR) has developed a fourth paradigm, tumor treating fields, which can inhibit the growth of tumors by inhibiting tumor cell division. In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com Contributor Brian Orelli discuss how the treatments work and the potential data readouts that Novocure will experience in 2021.